After more than eight years of treatments keeping her stage 3 ovarian cancer at bay, Jackie VanRaaphorst was running out of options when a new therapeutic targeting her disease was approved.
Read Jackie's StoryCancer is not a single disease, but rather a collection of diseases all characterized by the uncontrolled proliferation of cells.
Learn MoreThirty eminent scientists whose pioneering discoveries have accelerated progress in cancer science and medicine have been elected Fellows of the AACR Academy, Class of 2024.
Learn MoreWilms tumor is the most common form of childhood kidney cancer. Overall, kidney cancers account for about 7 percent of childhood cancers.
Learn MoreWhat is Cancer Precision Medicine? Research has powered an explosion in our understanding of the biology of cancer genomics and is leading to tailored treatments for patients.
Read the ReportThe current issue of Leading Discoveries magazine is available with articles on CAR T-cell pioneer Carl H. June, MD, FAACR, research updates from the AACR journals and scientific meetings, and more.
Read Leading DiscoveriesWhether honoring a special person or a special day, a donation to the American Association for Cancer Research has a lasting impact.
Donate NowThe official news website of the AACR Annual Meeting 2024. Stay up to date on the latest developments from the most important cancer meeting in the world.
The AACR Cancer Progress Report 2023 provides a comprehensive overview of the latest research-driven advances against the collection of devastating diseases called cancer.
Learn MoreThe AACR and its more than 58,000 members worldwide are advancing a scientifically bold agenda against the collection of diseases we call cancer.
Learn MoreA new wave of research-driven discoveries and technological innovations are delivering – and will propel additional – transformative advances to save more lives from cancer..
Learn Morepercent decrease of the overall age-adjusted cancer death rate in the U.S. from 1991 to 2020
Learn Moretherapeutics were approved for new or expanded uses by the FDA from Aug. 1, 2022, to July 31, 2023
Learn Moremillion cancer survivors in the U.S. are living with, through, and beyond their disease thanks to research
Learn More